Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga May 27, 2014 at 08:12 AM EDT Durata Therapeutics (NASDAQ: DRTX) dipped 11.19% to $15.00 in pre-market trading. Durata Therapeutics confirmed the FDA approval of ... Read More >> Related Stocks: Jinkosolar Holding Company ADR Pilgrim's Pride Pinnacle Foods Inc Staples